BrusselsFrance’s Sanofi faces an EU antitrust probe.
Sanofi holds a dominant market position; the European Commission said it misrepresented rival flu vaccine Fluad’s clinical evidence to doctors in Germany and France.
Sanofi said it is cooperating fully; fines can reach 10% of global revenues if found in breach.
Sources: Financial Times News